<DOC>
	<DOCNO>NCT02191735</DOCNO>
	<brief_summary>This clinical investigation design demonstrate performance characteristic RAMP® cardiac test analyze RAMP® 200 non-laboratorial Operators point-of-care compare result sample analyze RAMP® Reader .</brief_summary>
	<brief_title>RAMP 200 / RAMP Cardiovascular Tests Point-of-Care</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>Study Arms A Troponin I ( ACS/MI ) 1 . Males Females , 18 year age old , race 2 . Has routine test order Troponin suspect Acute Coronary Syndrome / Myocardial Infarction ( ACS/MI ) per institutional guideline 3 . Willing voluntarily agree sign consent form ( applicable ) Study Arms B Myoglobin ( ACS/MI ) 1 . Males Females , 18 year age old , race 2 . Has routine test order Troponin suspect Acute Coronary Syndrome / Myocardial Infarction ( ACS/MI ) per institutional guideline 3 . Myoglobin test result fall within reportable range test report RAMP® Myoglobin IFU . 4 . Willing voluntarily agree sign consent form ( applicable ) Study Arms C CKMB ( ACS/MI ) 1 . Males Females , 18 year age old , race 2 . Has routine test order Troponin suspect Acute Coronary Syndrome / Myocardial Infarction ( ACS/MI ) per institutional guideline 3 . CKMB test result fall within reportable range test report RAMP® CKMB IFU . 4 . Willing voluntarily agree sign consent form ( applicable ) Study Arm D NTproBNP ( HF ) 1 . Males Females , 18 year age old , race 2 . Has routine test order NTproBNP BNP suspect Heart Failure ( HF ) per institutional guideline 3 . Willing voluntarily agree sign consent form ( applicable ) Study Arms A , B , C Troponin I , Myoglobin , CKMB ( ACS/MI ) 1 . Healthy Subjects 2 . Pregnant lactate 3 . Subjects cardiac marker test order 4 . Blood sample collect &gt; 24 hour prior screen 5 . Subjects without adequate volume surplus EDTA whole blood available require trial test 6 . Noncompliance protocol inclusion criterion Study Arm D NTproBNP ( HF ) 1 . Healthy Subjects 2 . Pregnant lactate 3 . Subjects cardiac marker test order 4 . Blood sample collect &gt; 24 hour prior screen 5 . Subjects without adequate volume surplus EDTA whole blood available require trial test 6 . Noncompliance protocol inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>